{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:03:22Z","timestamp":1756339402782,"version":"3.44.0"},"reference-count":18,"publisher":"BMJ","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DTB"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:p>Many people who complain of excessive sweating have primary hyperhidrosis. This idiopathic disorder is characterised by excessive, bilateral and roughly symmetrical sweating, most commonly affecting the axillae, palms, feet and face.1 For some patients, excessive sweating is intolerable as it stains and damages clothes, reduces confidence and limits social contact. Treatment options have been limited but now include botulinum toxin for severe axillary hyperhidrosis. Here we review treatments for primary focal hyperhidrosis, focusing on axillary sweating.<\/jats:p>","DOI":"10.1136\/dtb.2005.431077","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T16:15:40Z","timestamp":1216397740000},"page":"77-80","source":"Crossref","is-referenced-by-count":2,"title":["Treatments for excessive armpit sweating"],"prefix":"10.1136","volume":"43","member":"239","published-online":{"date-parts":[[2005,10,1]]},"reference":[{"key":"2025082701515905000_43.10.77.1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaad.2003.12.040","article-title":"US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national survey","volume":"51","author":"Strutton","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2025082701515905000_43.10.77.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.12.040"},{"key":"2025082701515905000_43.10.77.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.12.029"},{"key":"2025082701515905000_43.10.77.4","first-page":"311","article-title":"Current treatments for axillary hyperhidrosis","volume":"6","author":"Fitzgerald","year":"2004","journal-title":"Surg J R Coll Surg Edinb Irel"},{"key":"2025082701515905000_43.10.77.5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archderm.138.4.539","article-title":"Definition of axillary hyperhidrosis by gravimetric assessment","volume":"138","author":"Hund","year":"2002","journal-title":"Arch Dermatol"},{"key":"2025082701515905000_43.10.77.6","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.4.539"},{"key":"2025082701515905000_43.10.77.7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025082701515905000_43.10.77.8","unstructured":"Botox Summary of product characteristics, UK Allergan Ltd November 2004."},{"key":"2025082701515905000_43.10.77.9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","article-title":"Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised parallel group, double blind, placebo controlled trial","volume":"323","author":"Naumann","year":"2001","journal-title":"BMJ"},{"key":"2025082701515905000_43.10.77.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7313.596"},{"key":"2025082701515905000_43.10.77.11","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.6.731"},{"key":"2025082701515905000_43.10.77.12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.05059.x"},{"key":"2025082701515905000_43.10.77.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102153440704"},{"key":"2025082701515905000_43.10.77.14","first-page":"703","article-title":"Treating hyperhidrosis. Anticholinergic drugs were not mentioned","volume":"321","author":"Klaber","year":"2000","journal-title":"BMJ"},{"key":"2025082701515905000_43.10.77.15","first-page":"1022","article-title":"Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis","volume":"28","author":"Proebstle","year":"2002","journal-title":"Dermatol Surg"},{"key":"2025082701515905000_43.10.77.16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1468-3083.2001.00226.x","article-title":"Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis","volume":"15","author":"Rompel","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025082701515905000_43.10.77.17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2001.00226.x"},{"key":"2025082701515905000_43.10.77.18","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199407000-00012"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2005.431077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:52:08Z","timestamp":1756284728000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2005.431077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2005,10,1]]},"published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1136\/dtb.2005.431077"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2005.431077","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}